Excess mortality related to cefepime

Lancet Infect Dis. 2010 May;10(5):293-4. doi: 10.1016/S1473-3099(10)70070-0.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anti-Bacterial Agents / adverse effects*
  • Anti-Bacterial Agents / therapeutic use
  • Bacterial Infections / drug therapy*
  • Bacterial Infections / mortality*
  • Cefepime
  • Cephalosporins / adverse effects*
  • Cephalosporins / therapeutic use
  • Humans
  • Mortality
  • Product Surveillance, Postmarketing / methods*
  • United States
  • United States Food and Drug Administration

Substances

  • Anti-Bacterial Agents
  • Cephalosporins
  • Cefepime